Page 2 - Marie Campinell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cue Biopharma to Host Business Update Call and Webcast

BOSTON, April 02, 2024 (GLOBE NEWSWIRE) Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells, announced

United statesMarie campinellJonathan pappasLifesci communicationsCorporate communicationsInternational investorsCue biopharma incOno pharmaceuticalSelective targeting

Cue Biopharma to Host Business Update Call and Webcast

BOSTON, April 02, 2024 Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells,.

United statesJonathan pappasMarie campinellCue biopharma incInternational investorsCorporate communicationsLifesci communicationsOno pharmaceuticalSelective targeting

Cue Biopharma s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium

Cue Biopharma s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMarie campinellAlexander dimitrios colevasJonathan pappasStanford university school of medicineStanford universityStanford cancer centerLifesci communicationsCue biopharma incCorporate communicationsNeck cancers symposiumStanford university schoolCue biopharmaSelective targeting

Cue Biopharma s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium -February 29, 2024 at 10:01 am EST

Cue Biopharma s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium -February 29, 2024 at 10:01 am EST
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesMarie campinellAlexander dimitrios colevasJonathan pappasCorporate communicationsCue biopharma incStanford cancer centerStanford university school of medicineStanford universityLifesci communicationsNeck cancers symposiumStanford university schoolCue biopharmaSelective targeting

Cue Biopharma s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium

Cue Biopharma s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMarie campinellJonathan pappasAlexander dimitrios colevasStanford university school of medicineStanford universityLifesci communicationsCorporate communicationsCue biopharma incStanford cancer centerLead clinical assetNeck cancersNeck cancers symposiumStanford university schoolCue biopharmaSelective targeting